Valeant (VRX) PT Cut to $11 at Mizuho
Tweet Send to a Friend
Mizuho Securities analyst Irina Koffler reiterated an Underperform rating on Valeant Pharmaceuticals (NYSE: VRX) and cut her price target to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE